| Literature DB >> 31996706 |
Sristy Shikha1, Saumya Ray Chaudhuri2, Mani Shankar Bhattacharyya3.
Abstract
Microbes develop several strategies to survive in the adverse condition such as biofilm formation, attaining non-dividing state, altering drug target or drug, thereby increases the burden of drug dosage. To combat these issues, nanoparticles have shown an alternative approach for new treatment strategy but synthesis via chemical synthetic route limits their application in biomedical field. Here, green method for the synthesis of gold nanoparticles using sophorolipid (SL) is discussed that is characterized by various techniques. Initially, the antimicrobial activity was checked against metabolically active state of microbes; Gram-positive Staphylococcus aureus and Gram-negative Vibrio cholerae using XTT assay and growth kinetics assay. Results suggested higher efficacy of nanoparticles for Gram-negative, therefore further analyzed against Escherichia coli that confirmed its potency for the same. AuNPs-SL also signifies its efficiency at least metabolically active state; non dividing cells and biofilm of these microbes. Induced morphological changes were studied by SEM that revealed AuNPs-SL led to disruption of cell membrane and leakage of intracellular fluid to the surroundings. Inhibition of respiratory enzymes activity also plays a crucial role in bactericidal action as indicated by LDH assay. Synergy of AuNPs-SL with different antibiotics was also analyzed using checkerboard assay. These results suggested the possible use of AuNPs-SL as an antimicrobial therapy in the field of nanomedicine.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31996706 PMCID: PMC6989514 DOI: 10.1038/s41598-019-57399-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1UV-visible spectra of gold nanoparticles synthesized by two different methods as indicated (A) TEM images of AuNPs-SL synthesized by two different method in absence (B-i) and presence (B-ii) of sodium borohydride (indicated as SBH) TGA (C) and FTIR spectra of SL (D-i) & AuNPs-SL (D-ii).
The antimicrobial activity of AuNPs-SL by agar diffusion method against gram positive Staphylococcus aureus and gram negative Vibrio cholerae.
| Samples | Zone of inhibition (in mm) | |
|---|---|---|
| AuNPs from Sigma | 0 | 0 |
| AuNPs-SL | 15 | 15 |
| SL | 15 | 0 |
| Ampicillin (50 µg/ml) | 28 | 8 |
Figure 2Antimicrobial activity of AuNPs-SL by XTT Assay and effect on growth kinetics against S. aureus (A,C) & V. cholerae (B,D). Bar graph (A,B) was analyzed using Two-way ANOVA, *P value < 0.01.
Figure 3Antibiofilm activity of AuNPs-SL against S. aureus (A) and V. cholerae (B) by CV (grey colour) and XTT assay (black colour). Experiment was performed in triplicate and graph was plotted using GraphPad Prism 6.0 using average value with SD.
Figure 4AuNPs-SL activity on preformed biofilm against S. aureus (A) and V. cholerae (B) by CV (grey colour) and XTT assay(black colour). Experiment was performed in triplicate and graph was plotted using GraphPad Prism 6.0 using average value with SD.
Figure 5Antimicrobial activity on non-dividing cells of S. aureus (A) and V. cholerae (B) by XTT assay. Data was analyzed using Two-way ANOVA. *P value < 0.01.
Figure 6Untreated cells of V. cholerae (A,E) S. aureus (C,G) whereas AuNPs-SL treated cells V. cholerae (B,F) and S. aureus (D,H) by SEM (upper panel) and TEM (lower panel).
Figure 7LDH activity of S. aureus (A) and V. cholerae (B). Average of triplicates was plotted with SD and data was analyzed using Two-way ANOVA (GraphPad Prism 6.0). *P value < 0.01.
MIC of individual drugs ampicillin, kanamycin, polymyxin and AuNPs-SL and FIC of these drugs with AuNPs-SL.
| Species | Ampicillin | Kanamycin | Polymyxin | AuNPs-SL | MIC (µg ml−1) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ampicillin + AuNPs-SL | Kanamycin + AuNPs-SL | Polymyxin + AuNPs-SL | ||||||||
| FIC(A) | FIC(B) | FIC(A) | FIC(B) | FIC(A) | FIC(B) | |||||
| 0.39 | 25 | 3125 | 50 | 0.195 | 25 | 6.25 | 6.25 | 390.65 | 12.5 | |
| 16 | 32 | 3125 | 50 | 50 | 16 | 16 | 12.5 | 390.65 | 6.25 | |
FICI of drugs ampicillin, kanamycin, polymyxin with AuNPs-SL.
| Species | Ampicillin + AuNPs-SL | FICI | Polymyxin + AuNPs-SL |
|---|---|---|---|
| Kanamycin + AuNPs-SL | |||
| 1(A) | 0.375(S) | 0.375(S) | |
| 2(I) | 0.75(PS) | 0.25(S) |
FIC of antibacterial A = MIC of antibacterial A in combination/MIC of antibacterial A alone.
FIC of antibacterialB = MIC of antibacterial B in combination/MIC of antibacterial B alone.
FIC index (FICI) = FIC of antibacterial A + FIC of antibacterial B.
FICI < 0.5 synergy(S), 0.5 ≤ FICI < 1 partial synergy(PS),
FICI = 1 additive(A), 2 ≤ FICI < 4 indifferent(I), and 4 < FICI antagonism.